Casandra
Casandra Test Code PG28470Version 1 (DRAFT)
Performing Lab
Lab Prevention GeneticsLab Test ID 7523
Von Hippel-Lindau Disease via VHL Gene
Clinical Use
Order TestUse
This test is intended for individuals with relevant clinical features who have a suspected diagnosis, or who have a family member with presumed or genetically-confirmed Von Hippel-Lindau disease. It is also useful for reproductive partners of individuals with a known pathogenic variant in the VHL gene.
Special Instructions
Not provided.
Limitations
The test performance characteristics have not been cleared or approved by the US Food and Drug Administration. Interpretation is dependent on quality clinical information provided.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
VHL Gene Analysis • Targeted
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided